Delivery Order SPE2DB22D9316-SPE2DB25FYN36
Award Date
2/12/25
Potential Completion Date
3/6/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $81,476.40 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized medication product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, at a ceiling value of $15,761.76. The delivery order has a firm fixed price pricing structure and runs through June 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,432.80 fixed-price contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a performance period ending on November 25, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of...
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on March 23, 2023. The contract, valued at $32,409.60, is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,291.93, is for the delivery of EYLEA 2MG/0.05ML SY 1S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract has a firm fixed-price pricing type and a completion date of May 15, 2024. DMS Pharmaceutical Group Inc. has a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $27,230.40 and covers the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a branded pharmaceutical product. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $26,269.60 firm fixed-price contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, which allows DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across a variety of medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $134,355.50, was issued against an existing indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply various medical supplies and pharmaceutical products to support military treatment facilities globally. The delivery order has a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,583.86 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of EYLEA 2MG/0.05ML SY 1S, a pharmaceutical product. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA, valued at up to $4,999,999 through 2025, which enables the agency to order a broad range of pharmaceutical items to...
This firm fixed-price delivery order, valued at $40,443.20, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML to support the recurring pharmaceutical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...